Institutional Variance in Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction in

Hayato Yamana1,2, Seyune Lee3, Yi-Chieh Lin4

  • 1Data Science Center, Jichi Medical University, Shimotsuke, Japan.

Insights

This study compared hospital variations in mortality after percutaneous coronary intervention for acute myocardial infarction across Korea, Japan, and Taiwan. While outcomes were generally uniform, Japan showed higher institutional mortality variance not fully explained by hospital factors.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Comparative Effectiveness

Background:

  • Studies often compare acute myocardial infarction (AMI) outcomes internationally, but institutional variations within countries are less explored.
  • Understanding hospital-level differences in outcomes is crucial for improving care quality.
  • This research addresses the gap by examining institutional variance in mortality after percutaneous coronary intervention (PCI) for AMI.

Purpose of the Study:

  • To compare institutional variance in inpatient mortality following PCI for AMI across three distinct health systems: Korea, Japan, and Taiwan.
  • To identify factors contributing to or explaining the observed institutional variance in mortality rates.

Main Methods:

  • Utilized nationwide inpatient data from Korea, Japan, and Taiwan for patients undergoing PCI for AMI in 2016.
  • Employed multilevel analyses to assess inpatient mortality, accounting for patient and hospital-level variables.
  • Compared intraclass correlation coefficients (ICC) and the proportion of variance explained by hospital characteristics.

Main Results:

  • Inpatient mortality rates were 6.3% (Korea), 7.3% (Japan), and 6.0% (Taiwan).
  • After adjustments, Taiwan exhibited the lowest mortality variation (ICC 1.8%), followed by Korea (2.2%) and Japan (4.5%).
  • Hospital characteristics explained 38% of variance in Korea, 19% in Taiwan, and 9% in Japan.

Conclusions:

  • Outcomes for patients undergoing PCI for AMI were broadly uniform across hospitals in Korea, Japan, and Taiwan.
  • Japan demonstrated a larger institutional variance in mortality compared to Korea and Taiwan.
  • A lower proportion of this variance in Japan was explained by measured hospital characteristics, suggesting other factors may be at play.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13